BackBone Ventures KEY CORPORATE FACTS / KPIS INVESTOR DESCRIPTION Offices Zurich BackBone Ventures stands for goal-oriented, value-adding and sustainable support for promising start-ups through network, capital and expertise. Our aim as a Swiss Venture Capital Firm based in Zurich is to find the most promising deals in the market and to bring in added value. Switzerland, Deutschland, Austria, Israel, BackBone's focus is on seed and start-up investments, primarily in the area of innovative ICT and disruptive technology projects. Active Markets Liechtenstein Founded 2018 Employees 5 (of which all in Europe) Current Fund Size n/a SELECTED PORTFOLIO COMPANIES Use of Debt No ImmunOs Therapeutics AG is leading the next generation of immunotherapies by fast-tracking new discoveries to enhance combination therapies with novel human immunomodulatory proteins that have a role in both the innate AUM and adaptive immune system for cancer treatment €1m By using stem cell research Supermeat produces synthetic poultry meat. Supermeat will revolutionize the poultry Target Investment Size €100k - €500k industry - clean, sustainable & pet friendly. Target Geographies primarily DACH Lawoon is an online platform for the placement of mini-jobs with automated payment processing. The Start-up allows bringing together clients and contractors in just a few clicks. Target Sectors ICT, Disruptive Technologies, Biotech Full Portfolio • www.backboneventures.ch/portfolio Investment Style Active KEY CONTACTS Deal Structures Minority Name Janic Frölicher [Photo] Title Investment Associate • B.B.A. Zurich University of Applied Science Key Investment Criteria Innovative & passionate • Rahn & Bodmer Co., VZ Vermögenszentrum, Credit Suisse AG Email: [email protected] Website www.backboneventures.ch Name Philippe Bernet Title Investment Manager • M.A. HSG Accounting & Finance Contact Email [email protected] • UBSAG, HA&W, Truventuro, Hermes Capital Email: [email protected] Contact Phone +41 44 500 23 81 INVESTOR BOOK 18